Comparision of the benefits and harm of indacaterol acetate and glycopyronium bromide with salmetrol and fluticasone in bronchial asthma patients.
Not Applicable
- Conditions
- Health Condition 1: null- Bronchial asthma
- Registration Number
- CTRI/2018/05/014079
- Lead Sponsor
- Aligarh Muslim University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.All patients of stable asthma diagnosed clinically and spirometrically with complaints of chest tightness and coughing particularly at night or in the early morning.
2.All patients with documented diagnosis of asthma for a period of at least 1 year as per GINA guideline.
Exclusion Criteria
1.Patients who had an asthma attack/exacerbation requiring systemic steroid/hospitalization.
2.Patients whoever had required intubation for severe asthma.
3.Patientâ??s clinical condition worsened by ICS administration.
4.Patients with a history of chronic lung disease other than asthma i.e. COPD, Sarcoidosis ,ILD
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SpirometryTimepoint: 0, 3rd, 7th, 14th & 28th day
- Secondary Outcome Measures
Name Time Method Renal function test, Hemogram,Liver function testTimepoint: 0 & 28th day